Mirum Pharmaceuticals, Inc. Increase Decrease In Operating Lease Liability
Mirum Pharmaceuticals, Inc. (MIRM) reported Increase Decrease In Operating Lease Liability of -$1.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-05
- Mirum Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$630.00K.
- Mirum Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$583.00K.
- Mirum Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$513.00K.
- Mirum Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$580.00K.
- Mirum Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2025 was -$1.90M.
- Mirum Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2024 was -$782.00K.
- Mirum Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2023 was -$940.00K.
- Mirum Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2022 was -$711.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$630.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.21M 10-Q · filed 2026-08-05 | -$1.73M derived: sum of 3 quarters · filed 2026-08-05 | -$2.31M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$583.00K 10-Q · filed 2026-05-06 | -$1.10M derived: sum of 2 quarters · filed 2026-05-06 | -$1.68M derived: sum of 3 quarters · filed 2026-05-06 | -$2.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$513.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.09M derived: sum of 2 quarters · filed 2026-02-25 | -$1.49M derived: sum of 3 quarters · filed 2026-08-05 | -$1.90M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$580.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$975.00K derived: sum of 2 quarters · filed 2026-08-05 | -$1.38M 10-Q · filed 2025-11-04 | -$1.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$395.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$803.00K 10-Q · filed 2026-08-05 | -$1.02M derived: sum of 3 quarters · filed 2026-08-05 | -$1.12M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$408.00K 10-Q · filed 2026-05-06 | -$622.00K derived: sum of 2 quarters · filed 2026-05-06 | -$728.00K derived: sum of 3 quarters · filed 2026-05-06 | -$921.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$320.00K derived: sum of 2 quarters · filed 2026-02-25 | -$513.00K derived: sum of 3 quarters · filed 2026-02-25 | -$782.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | -$106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$299.00K derived: sum of 2 quarters · filed 2025-11-04 | -$568.00K 10-Q · filed 2025-11-04 | -$797.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$462.00K 10-Q · filed 2025-08-06 | -$691.00K derived: sum of 3 quarters · filed 2026-02-25 | -$959.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$269.00K 10-Q · filed 2025-05-07 | -$498.00K derived: sum of 2 quarters · filed 2026-02-25 | -$766.00K derived: sum of 3 quarters · filed 2026-02-25 | -$990.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$497.00K derived: sum of 2 quarters · filed 2026-02-25 | -$721.00K derived: sum of 3 quarters · filed 2026-02-25 | -$940.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | -$268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$492.00K derived: sum of 2 quarters · filed 2024-11-12 | -$711.00K 10-Q · filed 2024-11-12 | -$894.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | -$224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$443.00K 10-Q · filed 2024-08-07 | -$626.00K derived: sum of 3 quarters · filed 2025-02-26 | -$809.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | -$219.00K 10-Q · filed 2024-05-08 | -$402.00K derived: sum of 2 quarters · filed 2025-02-26 | -$585.00K derived: sum of 3 quarters · filed 2025-02-26 | -$760.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$366.00K derived: sum of 2 quarters · filed 2025-02-26 | -$541.00K derived: sum of 3 quarters · filed 2025-02-26 | -$711.00K 10-K · filed 2025-02-26 |
| 2022-09-30 | -$183.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$358.00K derived: sum of 2 quarters · filed 2023-11-02 | -$528.00K 10-Q · filed 2023-11-02 | -$692.00K derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-06-30 | -$175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$345.00K 10-Q · filed 2023-08-07 | -$509.00K derived: sum of 3 quarters · filed 2024-03-15 | -$673.00K derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-03-31 | -$170.00K 10-Q · filed 2023-05-04 | -$334.00K derived: sum of 2 quarters · filed 2024-03-15 | -$498.00K derived: sum of 3 quarters · filed 2024-03-15 | -$662.00K derived: sum of 4 quarters · filed 2024-03-15 |
| 2021-12-31 | -$164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$328.00K derived: sum of 2 quarters · filed 2024-03-15 | -$492.00K derived: sum of 3 quarters · filed 2024-03-15 | -$649.00K 10-K · filed 2024-03-15 |
| 2021-09-30 | -$164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$328.00K derived: sum of 2 quarters · filed 2022-11-09 | -$485.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$321.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$157.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$385.00K 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |